Who Should Consider Stem Cell Evaluation: Criteria and Guidelines for Better Quality of Life

Individuals Seeking Joint and Muscle Restoration

The primary candidates for stem cell evaluation are those suffering from osteoarthritis or injuries to tendons and cartilage. Autologous adipose-derived stem cells (ADSCs) have the potential to differentiate into chondrocytes and reduce inflammation within joints without the need for major surgery.

In cases of rheumatoid arthritis, caused by immune system dysregulation attacking the joints, EHL BIO has developed technologies to rebalance immune cell functions and minimize tissue damage. A medical evaluation helps patients understand the goals for restoration and improved quality of life based on EHL team assessments.

Patients with Chronic Internal Organ Diseases

For those facing chronic kidney disease (CKD) or liver cirrhosis, stem cell evaluation represents an option in regenerative medicine. Currently, EHL BIO is in the medical development stage of using urine-derived stem cells (KDSTEM) for kidney care, which has shown initial results in reducing fibrosis and inhibiting inflammation.

Additionally, patients with liver cirrhosis caused by inflammation leading to scarring can undergo evaluation to use stem cells for creating new liver tissue and improving metabolic functions. Accessing these innovations helps build confidence in physical care and a foundation for systematic restoration and quality of life goals.

EHL BIO's goal is to care for patients through regenerative medicine, delivering better quality of life and longevity to all.

Those with Neurological Disorders and Age-Related Decline

Alzheimer’s and Parkinson’s are neurological conditions that impact daily life. Candidates for evaluation include those experiencing early memory loss or loss of muscle control. Stem cells possess a 'Homing Effect,' allowing them to identify brain damage and promote neuronal repair.

EHL BIO focuses on utilizing advanced technologies to manage symptoms and improve patient quality of life. Current research indicates that cell therapy can help improve cognitive and physical responses, aligning with 'Aging Well' goals according to EHL team assessments to ensure individuals enter old age with health and happiness.

Individuals Seeking Immune and Skin Restoration

Individuals suffering from acute or chronic Atopic Dermatitis should consider evaluation for ADSTEM, which is currently in Phase 3 clinical trials, focusing on rebalancing the immune system and restoring the skin barrier.

Furthermore, those seeking deep skin health care or facing dermal aging can be evaluated for Exosome or Conditioned Media products cultured under GMP standards, which stimulate collagen production and reduce skin pigmentation. These innovations help repair skin tissue from the inside out for sustainable results.